Demetrios G. Vavvas,Joan W. Miller,Lucia Sobrin,Jun Suzuki
申请号：
US15624172
公开号：
US20180036329A1
申请日:
2017.06.15
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Provided are methods for treating ocular inflammatory disorders, including macular edema, using an AMP kinase activator, e.g., 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR). The method reduces inflammation, thereby minimizing the loss of vision or visual function associated with these ocular disorders.
